Supply chain management

Jan 23, 2023
To help hospitals and health systems meet demand during the current surge in respiratory illnesses for fever-reducing products to treat pediatric patients and adults unable to swallow solid oral dosage forms, the Food and Drug Administration Friday released guidance for outsourcing facilities…
Sep 13, 2022
America’s hospitals and health systems continue to deal with the difficult challenges of high inflation and ongoing effects of the COVID-19 pandemic. Specifically, hospitals are facing significant increases in costs of labor from workforce shortages, drugs, equipment and supplies (including food…
Jun 29, 2022
The AHA will continue to monitor the baby formula supply shortage and work with hospitals to ensure access to the needed supplies. Explore AHA’s and resources from the FDA, White House, HHS and others on this page.
Jun 27, 2022
The Department of Health and Human Services’ Office on Trafficking in Persons last week issued a request for information on forced labor in health care supply chains to inform implementation of the National Strategy for a Resilient Public Health Supply Chain and related efforts on forced labor.
Jun 8, 2022
The Food and Drug Administration’s (FDA) Commissioner Robert Califf reported yesterday in a call with AHA and other stakeholders that progress has been made in addressing the shortage of infant formula.
Jun 7, 2022
Many hospitals have centralized 3D facilities for point-of-care manufacturing. The FDA has approved hundreds of medical products made with 3D technology. Three areas impacted are implants and prosthetics, anatomical models, and medical equipment.
May 20, 2022
Leaders from GE Healthcare May 18 joined AHA in a webinar designed to provide members with an update on the contrast dye shortage. During the webinar, GE Healthcare General Manager for Contrast Media in the United States, Greg Eppink, shared that the firm’s production capacity is improving and that…
May 16, 2022
The AHA letter to GE regarding the current supply disruptions and shortages of Omnipaque as a result of the temporary closure of GE Healthcare’s (GE) manufacturing facility in Shanghai, China.